Carniject can be administered intravenously for rapid therapeutic effect in clinical settings
Forward-looking statements in this news release include, but are not limited to, statements regarding the development, advancement, regulatory pathway, and potential commercialization of BNT23001, the Company's patented sublingual Cladribine orally dissolvable film ("ODF") program for multiple sclerosis
Retatrutide is an investigational triple agonist medicine that simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Liver Health Improvements GLP-1 therapy has been linked to reduced liver fat accumulation and improved liver enzymes
doi: 10.1038/s41580-020-00324-8 130 RatliffBBAbdulmahdiWPawarRWolinMS
We offer regular follow-up appointments to track your progress and make any necessary adjustments to your treatment plan